The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.

Download and Print: Download Printer-friendly PDF Download data

Table 26.21

Cancer of the Thyroid (Invasive)

United States Cancer Prevalence Estimates

Estimated United States Cancer Prevalence Counts a on January 1, 2017
By Race/Ethnicity, Sex and Years Since Diagnosis

Race/Ethnicity Sex Years Since Diagnosis Completee
0 to 5 >5 to 10 >10 to 15 >15 to 20 >20 to 25 <=25b >25d
All Races Both Sexes 231,706 190,426 126,803 80,597 56,569 686,101 173,737 859,838
Males 56,375 41,757 26,946 16,660 11,811 153,550 40,548 194,098
Females 175,330 148,669 99,857 63,937 44,758 532,551 133,189 665,740
White Both Sexes 195,432 163,435 111,041 71,352 50,080 591,341 153,707 745,047
Males 49,044 36,941 24,228 15,099 10,702 136,015 34,423 170,438
Females 146,388 126,494 86,813 56,253 39,378 455,326 119,283 574,609
Black Both Sexes 17,046 13,329 7,854 4,211 2,890 45,330 9,545 54,875
Males 3,157 2,180 1,295 669 503 7,803 1,444 9,247
Females 13,889 11,150 6,559 3,542 2,388 37,527 8,100 45,628
Asian/
Pacific
Islander		 Both Sexes 13,318 9,772 5,992 3,817 2,600 35,499 + +
Males 2,903 1,828 988 689 405 6,813 + +
Females 10,415 7,944 5,004 3,128 2,195 28,686 + +
Hispanic Both Sexes 29,121 20,368 12,721 7,789 5,169 75,168 + +
Males 5,359 3,352 2,028 1,235 825 12,800 + +
Females 23,762 17,015 10,693 6,554 4,343 62,368 + +

Estimated prevalence percent a on January 1, 2017, of the SEER population diagnosed in the previous 25 years
By Age at Prevalence, Race/Ethnicity and Sex

Race/Ethnicity Sex Age Specific (Crude) Age-Adjustedc
All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages
All Races Both Sexes 0.2117 0.0002 0.0068 0.0510 0.1608 0.3079 0.4016 0.4364 0.4433 0.3201 0.1925
Males 0.0962 0.0002 0.0032 0.0173 0.0517 0.1160 0.1714 0.2330 0.2817 0.2263 0.0884
Females 0.3237 0.0002 0.0106 0.0863 0.2709 0.4967 0.6217 0.6205 0.5784 0.3785 0.2913
White Both Sexes 0.2337 0.0003 0.0078 0.0581 0.1803 0.3341 0.4327 0.4565 0.4564 0.3291 0.2066
Males 0.1085 0.0002 0.0035 0.0201 0.0577 0.1274 0.1864 0.2477 0.2957 0.2366 0.0953
Females 0.3567 0.0003 0.0123 0.0982 0.3072 0.5432 0.6734 0.6500 0.5939 0.3878 0.3149
Black Both Sexes 0.0995 - 0.0020 0.0163 0.0618 0.1627 0.2122 0.2701 0.3140 0.2105 0.1055
Males 0.0357 - 0.0013 0.0033 0.0160 0.0473 0.0795 0.1218 0.1543 0.1231 0.0412
Females 0.1584 - 0.0027 0.0294 0.1041 0.2650 0.3278 0.3886 0.4256 0.2542 0.1590
Asian/
Pacific
Islander		 Both Sexes 0.1702 - 0.0064 0.0423 0.1273 0.2634 0.3390 0.4113 0.3969 0.3042 0.1679
Males 0.0681 - 0.0034 0.0129 0.0436 0.0999 0.1366 0.1852 0.2197 0.1682 0.0717
Females 0.2642 - 0.0094 0.0718 0.2035 0.4080 0.5144 0.5934 0.5387 0.3930 0.2501
Hispanic Both Sexes 0.1293 0.0001 0.0073 0.0429 0.1285 0.2358 0.3209 0.3835 0.3990 0.2964 0.1598
Males 0.0436 - 0.0034 0.0112 0.0332 0.0738 0.1055 0.1619 0.1988 0.1727 0.0596
Females 0.2168 0.0002 0.0112 0.0774 0.2322 0.4025 0.5342 0.5803 0.5533 0.3731 0.2561

Footnotes:

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the Alaska Native Registry) and 1/1/2017 US population estimates based on the average of 2016 and 2017 population estimates from the US Bureau of the Census. Prevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years.

b Maximum limited-duration prevalence is 25 years for 1992-2017 data.

c Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groups.

d Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).

e Complete prevalence is obtained by summing <=25 and >25.

- Statistic not shown. Statistic based on fewer than 5 cases estimated alive in SEER for the time interval.

+ Not available.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.